Delivery Order SPE2DU25D4210-SPE2DU26FA910
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,234.63 to AmerisourceBergen Drug Corp on October 28, 2025, with an ultimate completion date of October 29, 2025. This firm fixed-price delivery order, issued under a non-set-aside competitive procurement, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The performance location is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,579.54 to AmerisourceBergen Drug Corp on November 5, 2025, with completion expected by November 6, 2025. This firm fixed price delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no set-aside designation and...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $31,726.08 to AmerisourceBergen Drug Corp on November 1, 2025, with an ultimate completion date of November 3, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $17,056.07 to AmerisourceBergen Drug Corp on August 25, 2025, with completion expected by August 26, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a $13,421.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 7, 2025, with an ultimate completion date of the same day. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at AmerisourceBergen's corporate office location in...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $10,316.76 to AmerisourceBergen Drug Corp on September 1, 2025, with completion targeted for September 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $34,900.39 to AmerisourceBergen Drug Corp on September 26, 2025, with an ultimate completion date of September 29, 2025. This firm fixed-price delivery order, issued as a competitive award with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a delivery order valued at $12,826.69 to AmerisourceBergen Drug Corp on October 21, 2025, with completion scheduled for October 22, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation, and the place of...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $11,715.90 to AmerisourceBergen Drug Corp on June 10, 2025, with an ultimate completion date of June 11, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a competitive award to the prime contractor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency Medical Supply Chain awarded a $50,396.40 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, with completion expected by September 15, 2025. This firm fixed-price contract is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively procured with no set-aside designation. AmerisourceBergen,...
- SPE2DU25D4210Indefinite Delivery Contract
- SPE2DU25D4210-SPE2DU26FA910Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,522.94 to AmerisourceBergen Drug Corp on November 6, 2025, under a firm fixed-price contract with an ultimate completion date of November 6, 2025. This delivery order, designated as a non-set-aside competitive award, is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a total ceiling value of $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems worldwide, including medications across multiple therapeutic domains. This delivery order represents a transaction within AmerisourceBergen's expansive role as a pharmaceutical prime vendor for the DLA, which leverages the company's capabilities to deliver brand-name and generic medications, vaccines, specialized medical supplies, and other healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative is expected to establish regional contracts with multiple contractors, positioning AmerisourceBergen as one of the key suppliers supporting the Department of Defense's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.5k | 11/6/25 |